Please use this identifier to cite or link to this item: http://hdl.handle.net/10419/176293
Authors: 
Pant, Manoj
Pande, Devyani
Year of Publication: 
2014
Series/Report no.: 
Working Paper 275
Abstract: 
With the ongoing trade normalisation process between India and Pakistan, opportunities to integrate have opened up between both countries. The pharmaceutical sector is crucial to health issues in developing economies and would be an ideal segment to focus on in improving trade relations between the two countries. Here, an empirical and theoretical analysis of India-Pakistan trade using some statistical indicators reveals low levels of current trade but huge trade potential. Since China has virtually dominated the trade scene in nearly all manufacturing sectors, this study also looks at the tripartite dynamics of trade in pharmaceutical items among India, Pakistan and China. An analysis of the China-Pakistan and the South Asia Free Trade Area Agreements reveals that while Pakistan does not give any favourable treatment to China in items on Pakistan's negative/sensitive list for India, there is some indication that the favourable tariff treatment to China in general may have affected India's low trade in pharma ceutical products with Pakistan. The study further argues that the opening up of the Pakistan pharmaceutical market to India would lead t o an increase in consumer surplus, given the advantages of competition. Since many items are already imported from China, the argument that India's imports would stifle domestic producers seems misplaced. Hence, non-discriminatory access to Indian products seems reasonable. A positive start could be the phasing out of Pakistan's negative list. The incorporation of trigger mechanisms would help appease the apprehensions of the pharmaceutical industry in Pakistan about an influx of pharmaceutical items from India. ...
Subjects: 
India-Pakistan
trade
pharmaceuticals
China
trade potential
trade complementarity
FDI
policy recommendations
JEL: 
F10
F13
F14
Document Type: 
Working Paper

Files in This Item:
File
Size





Items in EconStor are protected by copyright, with all rights reserved, unless otherwise indicated.